Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.

Percie du Sert N, Rudd JA, Apfel CC, Andrews PL.

Cancer Chemother Pharmacol. 2011 Mar;67(3):667-86. doi: 10.1007/s00280-010-1339-4. Epub 2010 May 28. Review.

2.

[Effectiveness of anti-emetics for the prophylaxis of cisplatin-induced delayed emesis: a systematic review].

Kubota Y, Mihara K, Ishii F, Ohno K, Ogata H, Makimura M, Kikuchi N, Kitano T.

Yakugaku Zasshi. 2004 Jan;124(1):1-11. Review. Japanese.

3.
4.

Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.

Celio L, Agustoni F, Testa I, Dotti K, de Braud F.

Tumori. 2012 May-Jun;98(3):279-86. doi: 10.1700/1125.12393. Review.

5.

Drug treatment of chemotherapy-induced delayed emesis.

Tavorath R, Hesketh PJ.

Drugs. 1996 Nov;52(5):639-48. Review.

PMID:
9118814
6.

Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.

Rojas C, Slusher BS.

Eur J Pharmacol. 2012 Jun 5;684(1-3):1-7. doi: 10.1016/j.ejphar.2012.01.046. Epub 2012 Mar 9. Review.

PMID:
22425650
7.

Mechanisms by which cancer chemotherapeutic drugs induce emesis.

Cubeddu LX.

Semin Oncol. 1992 Dec;19(6 Suppl 15):2-13. Review.

PMID:
1485177
8.

[Recent improvements in antiemetic therapy].

Roila F, Palladino MA, Ciccarese G, Basurto C.

Tumori. 1997;83(2 Suppl):S3-14. Review. Italian.

PMID:
9235727
9.

[Efficacy of ondansetron in acute and delayed cisplatin-induced nausea and vomiting].

Depierre A.

Bull Cancer. 1996 Feb;83(2):147-53. Review. French.

PMID:
8652909
10.

Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.

Hesketh PJ.

Support Care Cancer. 1994 Sep;2(5):286-92. Review.

PMID:
8000724
11.

Management of cisplatin-induced delayed emesis.

Hesketh P.

Oncology. 1996 Jun;53 Suppl 1:73-7. Review.

PMID:
8692555
12.

5-HT3 receptor antagonists for prevention of late acute-onset emesis.

Constenla M.

Ann Pharmacother. 2004 Oct;38(10):1683-91. Epub 2004 Aug 17. Review.

PMID:
15316106
14.

Optimal control of acute cisplatin-induced emesis.

Verweij J, de Wit R, de Mulder PH.

Oncology. 1996 Jun;53 Suppl 1:56-64. Review.

PMID:
8692553
15.

Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models.

Naylor RJ, Rudd JA.

Oncology. 1996 Jun;53 Suppl 1:8-17. Review.

PMID:
8692557
16.

Management of other non-cisplatin-induced emesis.

Schmoll HJ, Casper J.

Oncology. 1996 Jun;53 Suppl 1:51-5. Review.

PMID:
8692552
18.

[Serotonin and anticancer drug-induced emesis].

Minami M, Endo T, Hamaue N, Hirafuji M.

Yakugaku Zasshi. 2004 Aug;124(8):491-507. Review. Japanese.

19.

Delayed emesis following anticancer chemotherapy.

Kris MG, Pisters KM, Hinkley L.

Support Care Cancer. 1994 Sep;2(5):297-300. Review.

PMID:
8000726
20.

[Research on antiemetics: an Italian model of success].

Roila F.

Tumori. 1998 Jan-Feb;84(1 Suppl):S3-11. Review. Italian.

PMID:
9617377
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk